AI algorithms to refine drug design/optimisation

AI-augmented DEL technology

AI-augmented diagnostic of colorectal cancer

dMRI reference brain maps for neurodegenerative diseases

Macrocyclic Epitope Mimics (MEMs) toward superior antibodies

ML-based approaches for inferring in vivo effects of drug candidates

Morphing peptides into small molecule leads

New targets for underexploited phytocannabinoids

Next-generation luminescence- and BRET-based biosensors

PET tracers to assess brain distribution of drug candidates

Real-time PK Biosensor

Use of AI to optimize the world most accurate brain PET scanner for DD